Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.605
+0.215 (9.00%)
Jul 11, 2025, 12:08 PM - Market open

Daré Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
2327307015355
Upgrade
Market Cap Growth
-48.12%-10.87%-56.74%-54.05%178.42%240.92%
Upgrade
Enterprise Value
1422173110850
Upgrade
Last Close Price
2.393.123.719.9624.0016.08
Upgrade
PS Ratio
816.412774.4510.857.04--
Upgrade
PB Ratio
--4.51-6.036.343.95-47.78
Upgrade
P/TBV Ratio
---6.343.95-
Upgrade
P/FCF Ratio
3.525.63----
Upgrade
P/OCF Ratio
3.145.03----
Upgrade
EV/Sales Ratio
555.602228.745.973.06--
Upgrade
EV/FCF Ratio
2.394.52----
Upgrade
Debt / Equity Ratio
-0.37-0.22-0.280.040.01-0.66
Upgrade
Debt / FCF Ratio
0.590.27----
Upgrade
Asset Turnover
0.0000.090.20--
Upgrade
Quick Ratio
0.490.740.561.153.290.67
Upgrade
Current Ratio
0.560.850.861.363.450.91
Upgrade
Return on Equity (ROE)
---994.69%-124.12%-205.82%-
Upgrade
Return on Assets (ROA)
-86.98%-67.57%-59.02%-39.38%-77.08%-228.45%
Upgrade
Return on Capital (ROIC)
---482.86%-77.49%-126.42%-4046.95%
Upgrade
Earnings Yield
-7.93%-14.93%-99.03%-43.96%-25.26%-49.80%
Upgrade
FCF Yield
28.43%17.76%-129.65%-25.78%-18.79%-45.89%
Upgrade
Buyback Yield / Dilution
-13.25%-16.80%-3.23%-38.29%-103.23%-93.16%
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q